First Merchants came into this earnings season with a reputation as a steady Midwestern bank and a stock that had drifted, with the share price down over the past three months despite small gains in the last week. Q3 2026 snapped that narrative. The company posted earnings per share of US$1.09 on revenue of US$195.8 million, and the market reacted, with the stock climbing about 2% today.
The focus this quarter is on profitability. Net income of US$67.8 million and a stronger net interest margin point to a franchise that is extracting more value from its balance sheet than the recent share price suggested.
Like the profitability trend at First Merchants but want a wider set of banks and financials with sturdy balance sheets to compare it against? Line this quarter up against our list of solid balance sheet and fundamentals stocks (26 results) to see how it stacks up on resilience and fundamentals.
Q3 2026 Earnings Summary
-
Revenue (Q3 2026 vs. Q3 2025):US$195.8 million compared with US$161.8 million (up about 21%)
-
Net Income (Q3 2026 vs. Q3 2025):US$67.8 million compared with US$56.3 million (up about 20%)
-
Basic EPS (Q3 2026 vs. Q3 2025):US$1.09 compared with US$0.98 (up about 11%)
-
Net Interest Margin, NIM (Q3 2026 vs. Q3 2025):3.44% compared with 3.24% (higher margin on earning assets)
Earnings tell part of the story, but investors who care about what they are paying often pay closer attention to the cash that actually comes in and out of a business over time. When you look at First Merchants' cash flows rather than just this quarter's profit print, the stock could be a striking 48% undervalued .
First Merchants bullish story: execution checkpoints
Optimists argue First Merchants is quietly building a higher earning, more fee rich franchise. The key ambition is clear.
"Investments in digital platforms and internal tech efficiencies are starting to show up in the numbers, with Q2 2026 pretax pre provision earnings up 7.5% quarter on quarter to US$84.6m and 2% positive operating leverage. This signals ongoing potential for better net margins and earnings as revenue growth stays ahead of expense growth."
Q3 results are consistent with that picture. Adjusted pre tax pre provision earnings were US$83.7m, with ROA at 1.30% and PTIPP ROA at 1.59%. NIM reached 3.44%, and the adjusted efficiency ratio improved to roughly 53.9%, which indicates expenses remain under tight control.
First Merchants bear case: credit and capital costs
The worry has been that credit issues and expensive capital could quietly weaken the story. That concern is specific and testable.
"Greater use of higher cost capital instruments, such as the recent $100m of 6.75% subordinated notes, could offset the benefit of share repurchases and dividends if earnings growth does not keep pace with the additional interest expense. This would limit growth in earnings per share and reduce flexibility for future capital returns."
Q3 illustrates the trade off in motion. First Merchants issued US$100m of subordinated notes while repurchasing US$50.3m of stock year to date. EPS was US$1.09, up year on year, and CET1 of 11.22% indicates capital capacity. Management has also indicated that subordinated debt interest will partially offset margin gains in Q4.
The price and this Narrative do not agree. → Uncover what this Narrative says First Merchants is actually worth .
Hunt For Mispriced Earnings Power
First Merchants just showed how a single quarter can reset expectations without rewriting the whole story. The real opportunity sits in finding stocks that could be undervalued before sentiment catches up.
-
Company 1 - 41% below our estimate - taps AI data center and defense hardware demand while investing in higher end manufacturing capacity.
-
Company 2 - 50% below our estimate - shifts a lending focused model toward larger recurring fee streams as acquired branches are integrated onto a single platform.
-
Company 3 - 23% below our estimate - turns a cardiometabolic and obesity drug portfolio into a production scale up story tied to broader insurance coverage.
Those are three of them. See every one of the 30 undervalued companies on it →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include FRME .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
